# Internal Medicine Follow-Up V1 — Final Verification Summary

## 1. Purpose

This document records the final local-runtime verification summary for the Internal Medicine Follow-Up V1 LBF customization in OpenEMR IM Core.

This file closes the first LBF-based Internal Medicine MVP build phase.

It confirms that the model is:

- locally runtime verified
- Encounter Preview verified
- metadata verified through non-PHI `layout_options` checks
- GitHub documentation traced
- not production-ready yet
- not clinically validated yet
- not seed/script converted yet

## 2. Project Context

- Repository: DrMohammed2024/openemr-im-core
- Operational branch: master
- Runtime environment: Android / Termux
- OpenEMR runtime path: `/data/data/com.termux/files/home/openemr_im_git`
- LBF layout name: Internal Medicine Follow-Up V1
- LBF layout ID: `LBFim_followup_v1`
- Build method: OpenEMR UI first
- Verification method: Encounter Preview + Termux metadata verification
- Documentation method: GitHub documentation PRs

## 3. Architecture Alignment

This verification follows the OpenEMR IM Core Product Readiness Roadmap.

Current project architecture remains:

- controlled OpenEMR fork
- upstream-first
- LBF-first
- configuration-first before code changes
- no OpenEMR core-sensitive path modification
- no PHI in GitHub
- no credentials in GitHub
- no sensitive logs in GitHub
- no database dumps in GitHub
- no production readiness claim

## 4. Verified LBF Layout

The verified layout is:

- Layout name: Internal Medicine Follow-Up V1
- Layout ID: `LBFim_followup_v1`

This layout is intended to support structured Internal Medicine follow-up documentation.

## 5. Verified Groups and Fields

### 5.1 Visit Context

Status: Verified

Fields:

- Follow-up reason
- Visit type
- Main complaint
- Interval history since last visit

### 5.2 Vital Signs Review

Status: Verified

Fields:

- Blood pressure
- Heart rate
- Respiratory rate
- Temperature
- Oxygen saturation
- Weight
- BMI note

### 5.3 Chronic Conditions Review

Status: Verified

Fields:

- Hypertension status
- Diabetes status
- Dyslipidemia status
- CKD status
- Cardiovascular disease status
- Respiratory disease status
- Other chronic condition notes

### 5.4 Medication Review

Status: Verified

Fields:

- Current medication list reviewed
- Medication changes since last visit
- Medication adherence concerns
- Medication side effects
- Refill needs

### 5.5 Symptoms Review

Status: Verified

Fields:

- New symptoms since last visit
- Chest pain
- Shortness of breath
- Dizziness or syncope
- Edema
- Other symptom notes

### 5.6 Physical Exam Summary

Status: Verified

Fields:

- General appearance
- Cardiovascular exam
- Respiratory exam
- Abdominal exam
- Extremities exam
- Neurological exam

### 5.7 Assessment

Status: Verified

Fields:

- Assessment summary
- Problem list update
- Clinical risk level
- Differential notes

### 5.8 Plan

Status: Verified

Fields:

- Treatment plan
- Medication plan
- Lab orders plan
- Imaging plan
- Referrals plan
- Follow-up interval
- Patient instructions

### 5.9 Patient Safety and Follow-up

Status: Verified

Runtime group label:

- Patient Safety and Follow_up

Fields:

- Red flags reviewed
- Return precautions
- Follow-up responsibility
- Pending results follow-up
- Safety-net notes

## 6. Verification Evidence Completed

The following evidence types have been completed for the LBF MVP phase:

### Runtime evidence

Each completed group was verified using OpenEMR Encounter Preview.

### Metadata evidence

Each completed batch was verified using non-PHI metadata checks against the OpenEMR `layout_options` table.

### GitHub traceability evidence

Each verified batch was documented through GitHub Pull Requests.

### Safety evidence

Documentation confirms:

- no PHI was used
- no patient data was committed
- no credentials were committed
- no sensitive logs were committed
- no database dumps were committed
- no OpenEMR core-sensitive files were modified

## 7. Completed Pull Request Evidence

The following merged PRs support this verification summary:

- Repository verification report
- Chronic Conditions Review batch 1 runtime confirmation
- Chronic Conditions Review batch 1 database snapshot
- Chronic Conditions Review batch 2 runtime/database verification
- Medication Review batch 1 runtime/database verification
- Symptoms Review batch 1 verification
- Physical Exam Summary and Assessment batch 1 verification
- Product Readiness Roadmap
- Plan batch 1 verification
- Patient Safety and Follow-up batch 1 verification

## 8. Current Status

Internal Medicine Follow-Up V1 is now considered:

- local-runtime verified
- LBF MVP complete
- documentation traced
- suitable for controlled local demo with non-PHI data
- not suitable for real patient data yet
- not production-ready
- not clinically signed off
- not clean-install validated
- not converted to seed/script
- not security/privacy validated for live use

## 9. Known Limitations

The current LBF MVP has the following limitations:

- The model exists as runtime LBF configuration in the local OpenEMR database.
- The model has not yet been converted into a reusable seed/script.
- The model has not yet been tested on a clean OpenEMR installation.
- The model has not yet received formal clinical review signoff.
- RBAC and access-control validation are not yet complete.
- Backup and restore validation are not yet complete.
- Security and privacy baseline documentation is not yet complete.
- Deployment readiness has not yet been validated.
- Commercial/legal readiness has not yet been reviewed.
- The project does not currently claim production readiness.

## 10. Required Next Evidence Packages

Before production or commercial use, the following packages must be created and verified:

### Clinical Review Package

Recommended path:

`custom/im-core/docs/clinical-review/`

Purpose:

- physician review
- clinical completeness review
- safety-net review
- usability review
- clinical signoff template

### Seed/Script Package

Recommended path:

`custom/im-core/lbf/scripts/`

Purpose:

- convert runtime LBF configuration into a reusable script
- support reproducible installation
- support clean-instance testing

### Clean Install Verification Package

Recommended path:

`custom/im-core/docs/deployment/`

Purpose:

- verify the LBF model can be recreated on a clean OpenEMR instance
- confirm portability outside the original Termux runtime

### Security and Privacy Package

Recommended path:

`custom/im-core/docs/security/`

Purpose:

- RBAC matrix
- no-PHI GitHub policy
- backup/restore SOP
- audit-log review checklist
- access review checklist

### Demo Safety Package

Recommended path:

`custom/im-core/docs/demo/`

Purpose:

- safe demo operation
- no real patient data
- synthetic data only
- demo reset rules
- limited demo users

### Compliance and Legal Boundary Package

Recommended path:

`custom/im-core/docs/compliance/`

Purpose:

- OpenEMR GPL review
- medical-device-software boundary
- privacy/data protection notes
- commercial readiness notes
- client agreement requirements

## 11. Roadmap Alignment Checklist

- [x] This verification follows the OpenEMR IM Core Product Readiness Roadmap.
- [x] Internal Medicine Follow-Up V1 LBF MVP is locally verified.
- [x] Encounter Preview verification was completed.
- [x] Metadata verification was completed using non-PHI layout metadata.
- [x] GitHub traceability exists through merged documentation PRs.
- [x] No PHI is included.
- [x] No credentials are included.
- [x] No sensitive logs are included.
- [x] No database dumps are included.
- [x] No OpenEMR core-sensitive paths are modified.
- [x] This document does not claim production readiness.

## 12. Final Verification Statement

Internal Medicine Follow-Up V1 is verified as a local LBF MVP for OpenEMR IM Core.

This completes the first structured Internal Medicine LBF customization phase.

The project may now proceed to the next product-readiness stage:

1. Clinical Review Package
2. Seed/script conversion
3. Clean install validation
4. Security and privacy baseline
5. Demo safety package
6. Compliance and legal boundary review

This verification does not authorize production use with real patient data.
